Latest Breaking News On - Lilly zepbound - Page 1 : vimarsana.com

Gilead Stock Jumps After Its Weight-Loss Drug Emerges From Under The Radar

Gilead stock jumped Friday after surprising Wall Street with preclinical test results for an under-the-radar weight-loss drug.

Weight-loss drug forecasts jump to $150 billion as supply grows

As millions seek access to weight-loss drugs from Novo Nordisk and Eli Lilly , increasing supplies, possible wider usage and a growing number of would-be rivals are leading some experts to raise annual global sales forecasts for the treatments to about $150 billion by the early 2030s.

Weight-loss drug sale forecasts jump to $150bn as supply grows

Over 80 experimental obesity drugs have reached the human testing stage

Obesity Drug Stocks: Where to Invest Now

Analysis-Weight-loss drug forecasts jump to $150 billion as supply grows

Analysis-Weight-Loss Drug Forecasts Jump to $150 Billion as Supply Grows

Health: Weight-loss drug forecasts jump to $150 billion as supply grows

Analysis-Weight-loss Drug Forecasts Jump to $150 Billion as Supply Grows

As millions seek access to weight-loss drugs from Novo Nordisk and Eli Lilly, increasing supplies, possible wider usage and a growing number of would-be rivals are leading.

SA Asks: Is Eli Lilly or Novo Nordisk a better investment? (NYSE:LLY)

Eli Lilly (LLY) and Novo Nordisk (NVO) now boast the largest market caps in Big Pharma. But which stock is a better investment? SA analysts weigh in on the weight-loss drugmakers.

Macy's profit down in first quarter

Stories you may have missed from the world of business.